“…Levels of Letters to the Editor 361 VEGF have also been shown to be increased in plasma and skin lesions of psoriasis (1)(2)(3)(4), contributing to dermal vascularization. The VEGF level correlates with disease severity ofthe psoriasis (7,8). The present case suggests that EGFR signalling contributes greatly to the development of psoriatic skin lesions, since panitumumab, an anti-EGFR antibody, exhibited remarkable therapeutic effects on skin symptoms in the erythrodermic psoriasis patient.…”